Joshua D. Lee MD, MSc
Associate Professor – Section on Tobacco, Alcohol, and Drug Use
Joshua D. Lee MD, MSc, is an Associate Professor in Medicine and Psychiatry at NYULMC. He is board-certified in Internal Medicine and Addiction Medicine and is an attending physician at Bellevue Hospital Center, NYULMC, and in the NYC jails. A graduate of the Univ. of Tennessee School of Medicine and Princeton University, Dr. Lee completed a residency and chief residency in primary care internal medicine at NYU/Bellevue and a fellowship and MSc in health service research and clinical epidemiology at Cornell University.
His research focuses on novel treatments of addiction, criminal justice populations, re-entry drug treatment, and medical education surrounding substance abuse. Dr. Lee is the principal investigator of a 2008-2014 NIDA R01 evaluating extended-release naltrexone (XR-NTX) for opioid treatment among persons on parole and probation and a similar current NYU- and Alkermes-supported pilot of XR-NTX in NYC jails. Recently concluded projects include a 2006-2009 NIDA RCT assessing the role of counseling as an adjuvant to pharmacological therapy in opioid dependent patients, a 2007-2009 feasibility study of extended-release naltrexone for alcohol dependence in primary care, a 2006-2008 NIDA study of buprenorphine treatment before and after release from jail in NYC, and a 2006-2007 NYC DOHMH-funded effort of buprenorphine treatment expansion in primary care. Dr. Lee is part of the Addiction Medicine clinic at Bellevue, an attending on the Bellevue Detox Unit, a per diem physician in the NYC jails, and has an Addiction Medicine private practice at NYULMC.
- Extended-Release vs. Oral Naltrexone Alcohol Treatment in Primary Care
- Extended-Release Naltrexone Opioid Treatment at Jail-to-Community Re-entry